Asian shares looked to end a brutal week on a steadier note, helped by Chinese data showing retail sales in the world's second-biggest economy beat forecasts in October in a welcome sign for consumer ...

By Leo Marchandon (Reuters) -Dutch insurer Aegon said it was done selling non-core assets and would now focus on growing its remaining businesses, mainly in the U.S., after it raised its annual ...

Germany will let the future U.S. administration know of the damage that a "spiral of tariff hikes" would cause, a German government official said on Friday ahead of Chancellor Olaf Scholz's ...

Euro zone economic growth will pick up in 2025 and 2026 and inflation will continue to slow, the European Commission forecast ...

Big global investors are exiting popular trades that bet on U.S. President-elect Donald Trump’s tax and tariff policies ...

The German economy will continue to significantly underperform average growth in the euro zone until 2026, the forecasts of ...

Generali beat nine-month profit forecasts as lower claims and price increases offset a 930 million euro ($982 million) hit ...

Chip behemoth Nvidia is reporting quarterly results and global PMI data is rolling in as markets continue to digest the ...

Europe's STOXX 600 opened lower on Friday, dragged by technology and healthcare stocks, keeping the index on track for its ...

(Reuters) -Dutch insurer Aegon raised its full-year capital generation target on Friday after it beat market estimates for the key metric in the third quarter driven by its U.S. business. Its ...

The dollar was headed for its best week in more than a month on Friday, buoyed by expectations of fewer Federal Reserve rate ...

Halozyme Therapeutics said on Thursday it has proposed to buy German drug developer Evotec for about 2 billion euros ($2.10 billion), to bulk up its drug discovery and development portfolio. Halozyme ...